In their study, rapamycin treatment effectively blocked the HIF-1α activation in a gastric cancer cell line under hypoxia and reduced the size of the CD-31-positive vessel area, leading to decreased tumor growth in a subcutaneous implantation model. This evidence concerns the gene HIF1A and neoplasm.